Here is Petemantx’s actual iHub post. There are some

New Post Public Reply Private Reply Replies (0) Message Board
thefamilyman
760
Here is Petemantx’s actual iHub post. There are some significant differences from your version.

“Things are progressing, I am sure, but until the money firms up more Leo is keeping things close to the vest and I like this tactic. No need to be letting possible partners know our plans until they need to be known. Gives Leo a stronger negotiating position IMO.

OM advancement could be based on grants received so things currently could be on hold until Leo has a better idea of which direction he wants to go (partner prior to P3, after P3, or other) This should be a fairly inexpensive trial so IMO Leo will want to do it alone. Results of P3 could cause Leo to decide to take OM commercial alone - always an option as there is no competitor, delivery system very simple, distribution should be easy w/ sachets.

IBD has been mentioned that a P2 was expected in Q3 but then CV put everything on hold so IMO very good chance a P2 will start pretty soon in Q4. Again, I think IPIX does this alone and when very good results come back the value of B-IBD will have skyrocketed and then the time for a partnership may start taking hold. Definitely expect a partner for IBD.

Proctitis thru AS - Leo at the mercy of what AlphaSigma wants to do as to progress - they (AS) may wait to see how the P2 UC trial goes prior to doing their trial

Kevetrin - Again, money is the issue. I am sure leo wants to get the pill tox tests finalized ASAP so we can test the pill on healthy volunteers so pill could be used in complementary tests with current cancer treatments.

Who knows if Leo is thinking of franchising out most all indications and if he would prefer working with one main partner rather than a whole slew of different organizations and cultures.

For years we have only been along for the ride, now IPIX (especially if CV turns out very positive) is squarely in the drivers seat. No need to hurry, things are progressing nicely IMO”
1

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Indico Breach May Expose Thousands to Identity Theft

Updated Category News Views 4

Data Breach Unsettles Indico's Operations Well, this is the kind of headache nobody wants on their spreadsheet—the unpleasant fallout from a significant data breach is rocking Indico Data Solutions. When you hear words like 'unauthorized party' and 'exposed sensitive personal information,' it ought to make investors sit up and pay attention. On May 7, 2026, Indico, the...

Continue Reading
BC Mosaic App Store Unlocks New Tools for Researchers

Updated Category News Views 2

Unleashing Innovation Through Specialized Apps Oh boy, it's about time someone shook things up in the research game. BC Platforms has rolled out the BC Mosaic App Store, a move that's got research types buzzing from Zurich to... well, anywhere healthcare pokes its head. These guys aren't just throwing out some generic, run-of-the-mill tools. No sir, they've created a...

Continue Reading
Qapture Expands Global DeFi Reach with Key Acquisitions

Updated Category News Views 0

Qapture Investments just made a move in the digital finance space that's promising to turn some heads. From acquiring Flammarion Partners to snapping up Hermetik Trading's DeFi strategies, this Bermuda-based investment manager isn't here to play. Led by Frederick Pye, the firm's gearing up for an industry takeover by blending regulation with innovative digital finance...

Continue Reading
stackArmor Secures FedRAMP High: A Strategic Milestone

Updated Category News Views 2

stackArmor: Carving a Niche in Federal Cybersecurity Hey, not every day you wake up to find a company carving its niche in federal cybersecurity quite the way stackArmor is doing. They've recently got their hands on that elusive FedRAMP High authorization for The Armory. What's this mean in English? Well, for starters, these guys are showing they're serious about...

Continue Reading
Power Solutions Litigations Prompt Investor Caution

Updated Category News Views 0

A Storm Brews Over Power Solutions International Look, if you're holding Power Solutions International (NASDAQ:PSIX) in your portfolio, it's time to perk up. The air's thick with talk that Kuehn Law, the firm with a head for shareholder litigation, is on their case. They're poking around, seeing if some executives got a little too creative with the truth. Word on the...

Continue Reading
RMX's QuantrusX™: Transforming Edge Intelligence

Updated Category News Views 1

The Edge Gets Real RMX Industries is tearing up the old rulebook of intelligence with their latest move. They’re calling it Real-World Intelligence, and right off the bat, RMX (OTCQB:RMXI) makes it clear they're not here to sell us some dusty data center illusion anymore. They're putting intelligence where the action is, at the physical edge, and that's something you...

Continue Reading
HIMS Faces Class Action: Investors Eye Leadership

Updated Category News Views 0

Another Day, Another Lawsuit: Hims & Hers in Hot Water Here's the latest conundrum in the corporate world, folks. Hims & Hers Health, Inc. (NYSE: HIMS) is caught up in a class action lawsuit that could shake up the telehealth scene. Investors who found themselves knee-deep in losses during the class period from August 2025 to July 2026 might want to pay attention. The...

Continue Reading
AEC Firms Revamp Strategies Amid Talent Tug-of-War

Updated Category News Views 2

The State of Compensation in AEC Sit back and chew on this—AEC firms are playing a whole new ball game when it comes to compensating their talent. FMI Corporation’s 2026 Compensation Trends Study is putting a spotlight on what really goes on behind the scenes in architecture, engineering, and construction firms. This is about more than just tossing some coin for a...

Continue Reading
Battling Razor Bumps: Breaking a Persistent Cycle

Updated Category News Views 3

Understanding Razor Bumps: More Than a Cosmetic Annoyance Crossing Great Neck this morning, I stumbled across a curious release from Laser by Aleya. Apparently, the problem with those pesky razor bumps plaguing many isn't just skin-deep. For some, especially those with coarse or curly hair, each razor stroke starts a relentless cycle of irritation that's as grinding as...

Continue Reading
iRobot's Roomba Max 875: The Ultimate Cleaning Machine

Updated Category News Views 3

Roomba Max 875 Combo: Setting a New Standard Alright, folks, iRobot's at it again—unleashing what they tout as their beefiest cleaner to date, the Roomba Max 875 Combo Robot. It's a name that might twist your tongue, and this technological titan's feature list is equally complex. You know the routine with these fancy gadget launches: big promises, shiny features, but...

Continue Reading

Top 5 Most Recently Viewed Articles

Elk + Elk Welcomes Attorney Joshua Farrell to Their Team

Updated Category News Views 341

Elk + Elk Welcomes Joshua Farrell to Its Legal Team Elk + Elk is thrilled to announce the newest member of its legal team, Joshua D. Farrell, who has joined the firm as a personal injury and medical malpractice attorney. With a robust background in litigation and a strong focus on client satisfaction, Joshua is set to enhance the firm's advocacy for clients. His addition...

Continue Reading
Baird Reaffirms Positive Outlook for Voyager Therapeutics Stock

Updated Category News Views 80

Baird Reaffirms Outperform Rating for Voyager Therapeutics Baird has reiterated its Outperform rating for Voyager Therapeutics (NASDAQ: VYGR) and set an unwavering price target of $18.00. This ongoing support emphasizes a potentially impactful external factor for Voyager’s groundbreaking VY-TAU01 program. Importance of the Upcoming CTAD Conference Excitement is building...

Continue Reading
Exploring Trump's Vision for a United States Sovereign Wealth Fund

Updated Category News Views 266

Trump's Vision for a Sovereign Wealth Fund President Donald Trump has advocated for the establishment of a sovereign wealth fund (SWF) aimed at enhancing the financial stability and global leadership of the United States. Understanding Sovereign Wealth Funds A sovereign wealth fund is essentially a state-owned investment vehicle that manages a variety of assets, including...

Continue Reading
Empowering Crypto Investors: Flipido Learn's Innovative Platform

Updated Category News Views 167

Flipido Trading Center Launches Flipido Learn Flipido Trading Center is excited to announce the launch of Flipido Learn, a specialized educational platform designed to equip users with essential knowledge about cryptocurrency, trading strategies, and the intricacies of the digital market. This platform is part of Flipido's commitment to promoting responsible trading and...

Continue Reading
Brami's Italian Protein Pasta Now Available Nationwide

Updated Category News Views 461

Brami's Italian Protein Pasta Now Available Nationwide The Fastest-Growing Pasta Brand in the U.S. Brings the Taste of 'La Bella Vita' to More Americans Brami is excited to announce a significant milestone—the nationwide distribution of its acclaimed Italian Protein Pasta in Whole Foods Market. Known as the #1 fastest-growing pasta brand in the United States, Brami is...

Continue Reading